INNO4COV-19 Open Call aims to provide financial support to companies with the goal of accelerating the development and commercialization of innovative solutions that tackle COVID-19 and that have already been validated in lab environments (TRL6 or higher).
Eligibility criteria
Companies or small consortia of companies established in one of the EU Member States or H2020 associated countries.
The sectors of focus may include healthcare / medicine / biotech / biopharma, and IT-related topics (e.g. robotics, automation, electronics, nanotech, etc).
What we offer
Financial support
Up to EUR 100,000 (100% of the total cost of the project)
Tailored support
Guidance from a network of experts at a technical, business and regulatory level for bringing your innovation to the market
Access to specific facilities and infrastructure
Providing added value to your innovations
Media exposure
Highlights through our network
Key dates
We will consider applications in three different rounds.
NOVEMBER 2020 ROUND
Deadline: 30/11/2020 – Funding decision: +40days
MARCH 2021 ROUND
Deadline: 31/03/2021 – Funding decision: +40days
May 2021 ROUND
Deadline: 31/03/2021 – Funding decision: +40days
More News
tiakis: Treatment of COVID-19
tiakis Biotech AG announced today that a first patient has been dosed in the COMCOVID trial, a Phase Ib/II trial evaluating the Company’s key investigational ...
Read more …Natural substances show promise against coronavirus
Three natural compounds present in foods like green tea, olive oil and red wine are promising candidates for the development of drugs against the coronavirus. ...
Read more …Evotec: € 7.5 m grant for development of COVID-19 therapeutic
Evotec SE announced that the Company has been selected by the German Federal Ministry of Education and Research (“BMBF”) to receive a grant for the ...
Read more …